Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bruce Wendel currently holds 65,600 shares of GT Biopharma, Inc. (GTBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Wendel has been a net seller of GTBP stock. They have purchased $26.3K and sold $28.2K worth of shares.
Bruce Wendel's most recent insider trade was on Jun 9, 2026, when they sold 65,600 shares at $0.00 per share.
Bruce Wendel serves as Executive at GT Biopharma, Inc. (GTBP). They have executed 16 insider transactions totaling $54.5K over their tenure at the company.
Bruce Wendel holds the position of Executive at GT Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Bruce Wendel has shown a selling trading pattern, with $26.3K in total purchases and $28.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bruce Wendel was on Nov 10, 2009, when they sold $28.2K worth of ABII shares. This transaction involved 797 shares at $35.42 per share.
Bruce Wendel currently owns 65,600 shares of GT Biopharma, Inc. (GTBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bruce Wendel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bruce Wendel has 16 Form 4 filings on record as an insider at GT Biopharma, Inc..
Set alerts for Bruce Wendel and 40,000+ other insiders.